Add-on Acquisition • Life Science

Direct Biologics Acquires Paisley Laboratories

On November 17, 2018, Direct Biologics acquired life science company Paisley Laboratories

Acquisition Context

This is Direct Biologics’ 1st transaction in the Life Science sector.
This is Direct Biologics’ 1st transaction in the United States.
This is Direct Biologics’ 1st transaction in California.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	November 17, 2018
Target	Paisley Laboratories
Sector	Life Science
Buyer(s)	Direct Biologics
Deal Type	Add-on Acquisition

Target Company

Paisley Laboratories

La Costa, California, United States

Paisley Laboratories LLC is a provider of cGMP manufacturing facility in Florida. Paisley offers intellectual property surrounding proprietary methods for obtaining concentrated growth factors and exosomes from human mesenchymal stem cells and their utility. Paisley Laboratories LLC is based in La Costa, California.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Direct Biologics

St. Louis, Missouri, United States

Category	Company
Sector	Medical Products

DESCRIPTION

Direct Biologics LLC is a science-based manufacturer of regenerative medical products, including a robust line of biologic and kyphoplasty products. Direct Biologics LLC is based in St. Louis, Missouri.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: California	1 of 1
Country: United States	1 of 1
Year: 2018	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2018 M&A